Category: Finance

Each week, Stockhead’s resident day trader gives us a peek at the highs and lows of his trading diary and hints at what might be [more…]

If the biotech sector were a classroom, the teacher’s end-of-year report card would read something like: “a patchy but solid effort in trying conditions, with [more…]

A new report by CSIRO and AEMO has found that new build costs for electric generation, energy storage and hydrogen production in Australia have stabilised [more…]

Momentum investing works on the theory that strong stocks will continue to rise in price, while weak stocks will continue to decline. On the up [more…]

Neuren set to uphold momentum in 2024 as front-runner among biotechs with catalysts next year Dimerix’s first analysis outcome for its Phase 3 trial of [more…]

On Stockhead today, Dr Boreham’s End-of-Year ASX report card, who’s riding momentum into ’24, and biotechs with catalysts looking to pop. But first, the day [more…]

Luke Winchester CIO, Merewether Capital The big question: Will 2024 be the year of micro and small caps? “At the risk of being a barber [more…]

Have investors in one of Australia’s most dazzling home-grown ASX success stories missed the boat? Now worth just shy of $10 billion, the US-focused diagnostic [more…]

Garimpeiro had a sense something was up on his recent annual fishing trip to country Victoria. Relegated to the back seat of the car for [more…]

  Big lithium miners hold firm as impacts of lithium price rout hits home Core Lithium’s ~20% fall has had an uneven impact on other [more…]